(MHA); obtained by solidifying the liquid media with 1.2% (w/v) agar (Oxoid No. 3); the other solid medium was desoxycholate citrate agar (DCA, Oxoid). The pH was maintained at 7.2-7.4 for all the media. NA was used for tests with Gram positive bacteria and PA and DCA were used for the rest of the bacteria as needed.
Determination of Minimum Inhibitory Concentration (MIC) of the Extract
The MIC of the extract with respect to different test bacteria was accurately determined by agar dilution method. For agar dilution method the extract was dissolved in sterile distilled water and then added at concentrations of 0 (control), 5, 10, 20, 30, 40 and 50 mg/ml in molten NA and poured in Petridishes according to NCCLS.
11)
The organisms were grown in PW, and the overnight culture was spot-inoculated on the NA plates such that each inoculum contained 2ϫ10 6 CFU. The plates were incubated at 37°C, examined after 24 h and incubated further for 72 h, where necessary. The lowest concentration of the extract in a plate that failed to show any visible macroscopic growth was considered as its MIC. The MIC determination was performed in duplicate for each organism, and the experiment was repeated where necessary.
In Vivo Tests Swiss strain of male white mice weighing 18-20 g were used for the in vivo studies. Animals were maintained at standard conditions at 21Ϯ1°C and 50-60% relative humidity with a photoperiod of 14 : 10 h of light : darkness. Water and a dry pellet diet were given ad libitum. The virulence of the test strain S. typhimurium NCTC 74 was enhanced in the following manner: 0.1 ml of an overnight grown NB culture of S. typhimurium NCTC 74 was given intraperitoneally as the challenge to 3 mice. Next day, the animals were anaesthetized and dissected. Heart blood was aseptically collected from them, added to fresh NB and incubated at 37°C. From this, the pure culture of S. typhimurium NCTC 74 was cultivated and given as challenge to another set of mice in the same manner. After 5 such passages, the organism was administered as challenge to 4 batches of mice. The median lethal dose (MLD or LD 50 ) of the passaged strain corresponding to 0.95ϫ10 9 CFU/mouse suspended in 0.5 ml NB served as the challenge dose for all the groups of animals. 12) Reproducibility of the challenge dose was ensured by standardization of its optical density in a Klett Summerson colorimeter at 640 nm and determination of the CFU count in NA and MHA.
Four batches of 20 mice each were taken for the study. The first two batches (constituting one group) were administered 30 mg of extract (by injecting i.p. 0.2 ml from a stock solution containing 150 mg/ml of the extract) and the next two batches received 60 mg of extract (0.2 ml from a stock solution of 300 mg/ml of the extract). After 3 h, one batch from each of the above two groups was challenged with 50 MLD of S. typhimurium NCTC 74. A control group comprising 60 animals was also injected with the same organism and 0.1 ml of sterile saline in place of the extract 3 h before the challenge. The number of animals dying upto 100 h was recorded in each group to determine the protective capacity of compound (Table 2) .
In another in vivo experiment, the CFU counts in blood and liver and spleen homogenates in treated and untreated mice were determined. For this purpose two groups of mice (10 animals per group) were taken. All the animals were given a 50 MLD challenge dose; of these 50% received the extract (60 mg/mouse) 3 h before the challenge and the rest received saline (Table 3) . After 18 h all the mice were sacrificed, blood was collected individually from heart, and livers and spleens were removed aseptically and homogenized in tissue homogenisers. CFU counts of individual organs were determined separately. Statistical analysis of the data was performed using Student's t-test.
RESULTS

Bacterial Inhibitory Spectrum of the Extract
Twentyfive Staphylococcus aureus were tested, of which 2 were inhibited at 5 mg/ml, 7 at 10 mg/ml, 7 at 20 mg/ml, 3 at 30 mg/ml, 4 at 40 mg/ml, 2 by 50 mg/ml of the drug. Out of 5 strains of Bacillus spp., 1 strain was inhibited at 30 mg/ml, 1 strain at 40 mg/ml and 2 at 50 mg/ml of the extract (Table 1) .
In case of Gram negative bacteria, of 15 E. coli strains, 1 was inhibited at 5 mg/ml, 13 between 10 to 30 mg/ml and 1 at 50 mg/ml of the extract. In case of Salmonella spp., 3 strains were inhibited at 20 mg/ml, 2 each at 40 mg/ml and 50 mg/ml. In case of Shigella spp. 23 had MIC between 20-50 mg/ml. Two strains of Klebsiella spp. were inhibited at 30 mg/ml, 2 at 50 mg/ml. One strain of Pseudomonas spp. at 30 mg/ml, 1 at 50 mg/ml. The MIC of 11 out of 23 V. cholerae was found to be 10 mg/ml, 4 had MIC at 20 mg/ml, 4 at 30 mg/ml, 1 at 40 mg/ml and 3 at 50 mg/ml. One strain Enterobacter spp. was inhibited at 40 mg/ml.
One strain of Bacillus spp., 2 strains of Salmonella spp., 1 strain of Shigella spp., 1 strain of Klebsiella spp., 1 strain of Pseudomonas spp. and 1 strain of Enterobacter spp., were inhibited at a concentration above 50 mg/ml and were thus considered to be resistant.
In Vivo Protection by Extract The in vivo antibacterial effect was determined by administering 50 MLD dosages (0.95ϫ10 9 CFU in 0.5 ml of NB) of S. typhimurium NCTC 74 into different groups of mice with or without administration of extract (Table 2 ). In the group that received the challenge and saline (in place of the extract), 48 of 60 mice died within 100 h. In the other groups, which were administered different doses of extract only, mortality rate of mice was very low. The difference in the mortality was found to be significant (pϽ0.001) between the extract treated and the control groups.
The results of the experiment for the determination of the effect of extract on CFU/ml in blood and organs homogenates of mice revealed significant reduction of bacterial load in mice 18 h after the challenge (Table 3) as compared with the control (pϽ0.01).
DISCUSSION
The decaffeinated powder from green tea was seen to possess distinct antimicrobial action in vitro when tested against a battery of several Gram positive and Gram negative genera. While sensitive bacterial strains occurred among Staphylococcus spp., Shigella dysenteriae, Salmonella spp. and Vibrio
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Vol. 28, No. 11 cholerae (MIC 10-20 mg/ml), the drug was much less active with respect to Bacillus spp., E. coli, klebsiellae and pseudomonads. The mouse-virulent bacterial strain Salmonella typhimurium NCTC 74 could be inhibited at 20 mg/ml of the extract (Table 1) . Moreover, the compound was totally non-toxic to animals at very high concentrations. The animal experiments were undertaken to determine the relevance of green tea as an antibacterial agent to human usage. The protection offered by the compound to mice challenged with S. typhimurium NCTC 74 was found to be statistically highly significant (Table 2) .
Since tea is extensively used worldwide without any known toxic effect, the present extract from this popular beverage may, in course of time, be developed as a successful antimicrobial agent in many infections, making it even more acceptable. Further synergistic combinations of the extract with conventional antimicrobial agents might even improve its therapeutic property. Thus, this study along with our earlier studies [13] [14] [15] [16] have proved that various plants are still some of the rich sources of products with efficient medicinal values.
